When optimizing nanocarriers,
structural motifs that are beneficial
for the respective type of cargo need to be identified. Here, succinoyl
tetraethylene pentamine (Stp)-based lipo-oligoaminoamides (OAAs) were
optimized for the delivery of plasmid DNA (pDNA). Structural variations
comprised saturated fatty acids with chain lengths between C2 and
C18 and terminal cysteines as units promoting nanoparticle stabilization,
histidines for endosomal buffering, and disulfide building blocks
for redox-sensitive release. Biophysical and tumor cell culture screening
established clear-cut relationships between lipo-OAAs and characteristics
of the formed pDNA complexes. Based on the optimized alternating Stp-histidine
backbones, lipo-OAAs containing fatty acids with chain lengths around
C6 to C10 displayed maximum gene transfer with around 500-fold higher
gene expression than that of C18 lipo-OAA analogues. Promising lipo-OAAs,
however, showed only moderate in vivo efficiency. In vitro testing in 90% full serum, revealing considerable
inhibition of lytic and gene-transfer activity, was found as a new
screening model predictive for intravenous applications in
vivo.
Human transferrin protein (Tf ) modified polyplexes have already displayed encouraging potential for receptor-mediated nucleic acid delivery into tumors. The use of a blood-derived targeting protein and polydisperse macromolecular cationic subunits however presents a practical challenge for pharmaceutical grade production. Here, Tf receptor (TfR) targeted small interfering RNA (siRNA) polyplexes are designed that are completely composed of synthetic, monodisperse, and sequence-defined subunits generated by solid-phase supported synthesis. An optimized cationizable lipo-oligoaminoamide (lipo-OAA) is used for siRNA core polyplex formation, and a retro-enantio peptide (reTfR) attached via a monodisperse polyethylene glycol (PEG) spacer via click chemistry is applied for targeting. Improved gene silencing is demonstrated in TfR-expressing KB and DU145 cells. Analogous plasmid DNA (pDNA) polyplexes are successfully used for receptor-mediated gene delivery in TfR-rich K562 cells and Neuro2a cells. Six lipo-OAAs differing in their lipidic domain and redox-sensitive attachment of lipid residues are tested in order to evaluate the impact of core polyplex stability on receptor-dependent gene transfer.
In the field of systemically applied, nucleic acid-based drugs, polyplexes are interesting candidates for therapeutic systems. In this study, we synthesized a multifunctional triblock copolymer via reversible addition−fragmentation chain transfer (RAFT) block copolymerization. Due to three orthogonal reactive functionalities (an azide end group, a reactive disulfide block (P(PDSM)), and a reactive ester block (P(PFPMA))), the synthesized polymer system is highly adaptable and can be modified in a tailor-made fashion. After modification with N,N-dimethyl ethylendiamine (DMEDA), the synthesized cationic triblock copolymers form polyplexes with pDNA, even at low N/P ratios. The polyplexes can be stabilized further by crosslinking, having a size range of 113−151 nm in 10 mM NaCl, with high uniformity and low size distribution. ζ measurements indicate a good shielding of the charged polyplex core. Additionally, no significant cytotoxicity of the polyplexes is found. First transfection experiments are positive, but the gene transfer efficiency needs to be improved further. Because of its high modifiability, the presented triblock copolymer system is a good candidate for an adjustable pDNA transport system.
Nanomedicine has a great potential to revolutionize the therapeutic landscape. However, up-to-date results obtained from in vitro experiments predict the in vivo performance of nanoparticles weakly or not at all. There is a need for in vitro experiments that better resemble the in vivo reality. As a result, animal experiments can be reduced, and potent in vivo candidates will not be missed. It is important to gain a deeper knowledge about nanoparticle characteristics in physiological environment. In this context, the protein corona plays a crucial role. Its formation process including driving forces, kinetics, and influencing factors has to be explored in more detail. There exist different methods for the investigation of the protein corona and its impact on physico-chemical and biological properties of nanoparticles, which are compiled and critically reflected in this review article. The obtained information about the protein corona can be exploited to optimize nanoparticles for in vivo application. Still the translation from in vitro to in vivo remains challenging. Functional in vitro screening under physiological conditions such as in full serum, in 3D multicellular spheroids/organoids, or under flow conditions is recommended. Innovative in vivo screening using barcoded nanoparticles can simultaneously test more than hundred samples regarding biodistribution and functional delivery within a single mouse.
Taking advantage of effective intracellular delivery mechanisms of both cationizable lipids and polymers, highly potent double pH-responsive nucleic acid carriers are generated by combining at least two lipo amino fatty acids (LAFs) as hydrophobic cationizable motifs with hydrophilic cationizable aminoethylene units into novel sequence-defined molecules. The pH-dependent tunable polarity of the LAF is successfully implemented by inserting a central tertiary amine, which disrupts the hydrophobic character once protonated, resulting in pH-dependent structural and physical changes. This "molecular chameleon character" turns out to be advantageous for dynamic nucleic acid delivery via lipopolyplexes. By screening different topologies (blocks, bundles, T-shapes, U-shapes), LAF types, and LAF/aminoethylene ratios, highly potent pDNA, mRNA, and siRNA carriers are identified, which are up to several 100-fold more efficient than previous carrier generations and characterized by very fast transfection kinetics. mRNA lipopolyplexes maintain high transfection activity in cell culture even in the presence of ≥90% serum at an ultra-low mRNA dose of 3 picogram (≈2 nanoparticles/cell), and thus are comparable in potency to viral nanoparticles. Importantly, they show great in vivo performance with high expression levels especially in spleen, tumor, lungs, and liver upon intravenous administration of 1-3 μg luciferase-encoding mRNA in mice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.